Engineers have developed a neuroinspired hardware-software co-design approach that could make neural network training more energy-efficient and faster. Their work could one day make it possible to train neural networks on low-power devices such as smartphones, laptops and embedded devices.
Moderate to severe loneliness can persist across adult lifespans, but UC San Diego School of Medicine researchers found it is particularly acute in three age periods: late-20s, mid-50s and late-80s. Wisdom proved a protective factor.
After living with debilitating phantom leg pain for 18 years, Raul Silva is excited about a new dorsal root ganglion (DRG) stimulation device that erased his pain during a testing phase at UC San Diego Health, one of the only health care providers in the region offering the device.
UC San Diego scientists have been granted $2 million to develop new methods for manufacturing products based on algae. Biologist Stephen Mayfield will lead efforts to develop novel platforms to produce biologically based monomers that will be used to manufacture renewable and biodegradable products.
Since coding is fun to freshman Yuan Gao, creating his first word cloud from the Facebook page of Halıcıoğlu Data Science Institute at UC San Diego was basically entertainment. He created the montage-style graphic for a pass-fail elective class. Still -- how many people can hand-make a cloud?
UC San Diego researchers join national effort to better understand human immune system as part of new Allen Institute of Immunology.
The Trestles supercomputer, which was acquired more than three years ago by the Arkansas High Performance Computing Center (AHPCC) at the University of Arkansas after entering service at the San Diego Supercomputer Center in 2011, is still going strong.
David Cheresh, Distinguished Professor at University of California San Diego School of Medicine, received $4.2 million National Cancer Institute Outstanding Investigator Award to continue his research into cancer’s ability to overcome stress, gain drug resistance and metastasize.
Researchers find that patients with severe, refractory schizophrenia benefit from targeted cognitive therapy, improving auditory and verbal outcomes and the way they process information.
Researchers spent two years testing chemical compounds for their ability to inhibit the malaria parasite at an earlier stage in its lifecycle than most current drugs, revealing a new set of chemical starting points for the first drugs to prevent malaria instead of just treating the symptoms.